| Title |
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants
|
|---|---|
| Published in |
Cochrane database of systematic reviews, February 2015
|
| DOI | 10.1002/14651858.cd003481.pub6 |
| Pubmed ID | |
| Authors |
Arne Ohlsson, Rajneesh Walia, Sachin S Shah |
| Abstract |
Indomethacin is used as standard therapy to close a patent ductus arteriosus (PDA) but is associated with reduced blood flow to several organs. Ibuprofen, another cyclo-oxygenase inhibitor, may be as effective as indomethacin with fewer adverse effects. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 2 | 67% |
| United States | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 185 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 1% |
| Netherlands | 1 | <1% |
| Norway | 1 | <1% |
| Ethiopia | 1 | <1% |
| South Africa | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 178 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 22 | 12% |
| Student > Postgraduate | 21 | 11% |
| Student > Bachelor | 21 | 11% |
| Other | 19 | 10% |
| Researcher | 17 | 9% |
| Other | 46 | 25% |
| Unknown | 39 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 97 | 52% |
| Nursing and Health Professions | 15 | 8% |
| Agricultural and Biological Sciences | 4 | 2% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 2% |
| Biochemistry, Genetics and Molecular Biology | 3 | 2% |
| Other | 16 | 9% |
| Unknown | 46 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2015.
All research outputs
#6,471,669
of 25,806,763 outputs
Outputs from Cochrane database of systematic reviews
#8,077
of 13,140 outputs
Outputs of similar age
#66,606
of 269,900 outputs
Outputs of similar age from Cochrane database of systematic reviews
#167
of 286 outputs
Altmetric has tracked 25,806,763 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 269,900 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 286 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.